SAN.PA - Sanofi

Paris - Paris Delayed Price. Currency in EUR
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue34,708,000
Cost of Revenue10,702,000
Gross Profit24,006,000
Operating Expenses
Research Development-
Selling General and Administrative-
Non Recurring-
Total Operating Expenses27,184,000
Operating Income or Loss7,524,000
Income from Continuing Operations
Total Other Income/Expenses Net-
Earnings Before Interest and Taxes7,524,000
Interest Expense-274,000
Income Before Tax-
Income Tax Expense1,326,000
Minority Interest-
Net Income From Continuing Ops-
Non-recurring Events
Discontinued Operations314,000
Extraordinary Items-
Effect Of Accounting Changes-
Other Items-
Net Income
Net Income4,709,000
Preferred Stock And Other Adjustments-
Net Income Applicable To Common Shares-